New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
07:29 EDTRTIXRTI Surgical upgraded to Buy from Hold at Canaccord
As previously reported, Canaccord upgraded RTI Surgical to Buy from Neutral. The firm upgraded shares following the better than expected Q1 report and guidance citing a turnaround in the core business and strong momentum. Price target raised to $5 from $4.
News For RTIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 11, 2016
16:30 EDTRTIXRTI Surgical announces agreement with Oxford Performance Materials
RTI Surgical announced a new agreement with Oxford Performance Materials, or OPM, a pioneer in advanced materials and additive manufacturing for biomedical applications. The agreement, effective Feb. 4, 2016, grants RTI an exclusive license to OPM's OsteoFab technology platform for spinal applications in all U.S. markets. OsteoFab is a next-generation implant manufacturing process that builds implantable medical devices, layer-by-layer, using only laser light and OPM's OXPEKK polymer. The OsteoFab process and OXPEKK material combine to create implants that are designed to enable bone ongrowth. OXPEKK is a proprietary high-performance biocompatible polymer formulation from OPM, designed for medical applications. This strong, pure, radiolucent, hydrophilic, load-bearing material boasts a successful history in orthopedic implant applications. Under the agreement, OPM will manufacture RTI's spinal implant designs using OsteoFab technology, and RTI will oversee finishing steps, packaging, marketing and distribution of finished products.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use